Harbour Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,003
Closed -$903K 286
2024
Q2
$903K Sell
10,003
-315
-3% -$27.9K 0.21% 102
2024
Q1
$973K Sell
10,318
-75
-0.7% -$6.3K 0.24% 94
2023
Q4
$760K Sell
10,393
-1,282
-11% -$89.2K 0.21% 106
2023
Q3
$809K Sell
11,675
-6,246
-35% -$502K 0.24% 92
2023
Q2
$1.64M Sell
17,921
-552
-3% -$48K 0.48% 51
2023
Q1
$1.53M Sell
18,473
-9,578
-34% -$753K 0.46% 53
2022
Q4
$2.08M Sell
28,051
-8,235
-23% -$635K 0.7% 44
2022
Q3
$3M Sell
36,286
-80
-0.2% -$7.7K 1.04% 28
2022
Q2
$3.46M Sell
36,366
-35
-0.1% -$3.62K 1.13% 26
2022
Q1
$4.29M Buy
36,401
+311
+0.9% +$34.9K 1.17% 24
2021
Q4
$4.67M Buy
36,090
+180
+0.5% +$21K 1.15% 25
2021
Q3
$4.07M Buy
35,910
+661
+2% +$75.4K 1.07% 28
2021
Q2
$3.65M Sell
35,249
-235
-0.7% -$22.2K 0.98% 30
2021
Q1
$2.97M Buy
35,484
+945
+3% +$79.9K 0.87% 35
2020
Q4
$3K Buy
34,539
+730
+2% +$60.6K 1.49% 25
2020
Q3
$2.7M Buy
33,809
+146
+0.4% +$11.4K 0.99% 30
2020
Q2
$2.33M Sell
33,663
-9
-0% -$640 0.94% 33
2020
Q1
$2.12M Buy
33,672
+639
+2% +$46.1K 1.08% 29
2019
Q4
$2.57M Buy
33,033
+318
+1% +$24.8K 0.98% 27
2019
Q3
$2.4M Sell
32,715
-540
-2% -$37.9K 1.01% 26
2019
Q2
$2.05M Buy
33,255
+294
+0.9% +$17.8K 0.88% 34
2019
Q1
$2.1M Sell
32,961
-1,842
-5% -$105K 0.93% 28
2018
Q4
$1.78M Buy
34,803
+984
+3% +$49.8K 0.88% 31
2018
Q3
$1.96M Sell
33,819
-45
-0.1% -$2.2K 0.79% 33
2018
Q2
$1.65M Sell
33,864
-105
-0.3% -$4.9K 0.71% 41
2018
Q1
$1.58M Buy
33,969
+948
+3% +$41.2K 0.67% 43
2017
Q4
$1.24M Buy
33,021
+4,785
+17% +$176K 0.52% 64
2017
Q3
$1.03M Buy
28,236
+17,775
+170% +$678K 0.45% 74
2017
Q2
$412K Buy
10,461
+7,485
+252% +$273K 0.2% 143
2017
Q1
$93.3K Buy
+2,976
New +$93.2K 0.04% 302

Other funds holding EW